Brainose Technologies

Nasal Delivery of Cannabis-derived Therapeutics

Health Tech & Life Sciences
Non Active, Mar 2019 ceased to operate
Pre-Funding Rosh Haayin, Israel Founded 2017
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2017
Headcount
6
HQ
Rosh Haayin, Israel
Sector
Health Tech & Life Sciences

About

Brainose Technologies has developed a nose-to-brain delivery system for cannabis-derived therapeutics for the treatment of central nervous system (CNS) indications. Brainose is currently developing a pharmaceutical-grade cannabinoid-based therapy with a focus on pain management for FDA and CE approval in the U.S. and Europe. The companys mission is to provide the huge population that benefits from cannabis-derived therapeutics with accessibility to these medications in a simple, safe, efficient, and friendly manner. Its products are designed to ensure precise and reproducible dose delivery. Brainose was founded as a collaboration between Cann10, an accelerator focused on medical cannabis, and Nextar Chempharma Solutions, a veteran pharmaceutical company. Brainose has partnered with SipNose to further progress on its drug delivery platform.

Q&A

What is Brainose Technologies' primary focus?
Brainose Technologies focuses on developing a nose-to-brain delivery system for cannabis-derived therapeutics, specifically for central nervous system (CNS) indications, with a current emphasis on pain management.
When was Brainose Technologies founded?
Brainose Technologies was founded in January 2017.
What is the current status of Brainose Technologies?
Brainose Technologies is currently inactive, having ceased operations in March 2019.
How many employees did Brainose Technologies have?
Brainose Technologies had 1-10 employees.
Who are the co-founders of Brainose Technologies?
The co-founders of Brainose Technologies are Yossi Bornstein, who also served as CEO, and Ofer Spottheim.
What was Brainose Technologies' product stage?
Brainose Technologies was in the R&D stage for its products.
What was Brainose Technologies' primary sector?
Brainose Technologies' primary sector was Health Tech & Life Sciences.
Has Brainose Technologies secured any patents?
Yes, Brainose Technologies holds one patent.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug Delivery
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B

Highlights

1 Patents

Tags

healthcare-providersneurologypain-relieftherapeuticsmedical-cannabismedical-devicespharmaceuticalsdrug-deliverypharma-companiespatients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2017-1
Employees (exact)6
Status reasonNon Active, Mar 2019 ceased to operate